Srs Capital Advisors, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Srs Capital Advisors, Inc.
- $8.6 Billion
- Q3 2025
A detailed history of Srs Capital Advisors, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 301 shares of ARCT stock, worth $2,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
301
Previous 91
230.77%
Holding current value
$2,188
Previous $1,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARCT
# of Institutions
171Shares Held
26.2MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...